1Edmond MB,Wallace SE,MacClish DK,et al.Nosocomial Bloodstream infection in United States hospitals:a three-year analysis[J].Clin Infect Dis,1999,29 (2):239-282.
2Smith TL,Pearson ML,Wilcox KR,et al.Emergence of vancomycin resistance in Staphylococcus aureus[J].N Engl J Med,1999,340(7):493-501.
3Mutnick AH,Biedenbach DJ,Jones RN.Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997 -2000)[J].Diagn Microbiol Infect Dis,2003,46,63-70.
4hani KM, Weigeh J, Li JZ, et al. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA) [ J]. Int J Antimicrob Agents,2005,26:442 -448.
5Weigeh J, Itani K, Stevens D, et al. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections [ J ]. Antimicrob Agents Chemother,2005 ,49 :2260 - 2266.
6Song JH, Lee NY, Ichiyama S, et al. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study[ J ]. Clin Infect Dis, 1999,25:1206 - 1211.
7Hill EE, Herijgers P, Claus P, et al. Infective endocarditis: changing epidemiology and predictors of 6-month mortality : a p rospecrive cohortstudy[ J]. Eur Heart J,2007,28 : 196 - 203.
8Gilbert DN, MoeHefing RC Jr, Eliopoulos GM, et al. The Sanford Guide to Antimicrobial Therapy [ M ]. Antimicrobial Therapy, Inc. ( Hyde park, TV) ,2005.
